sot101,pembrolizumab
merck,sotio
['sot101 ', 'pembro']
happy to see the promising results of aurelio-3 in #asco2022 : 15 out of 19 patients receiving sot101 + pembrolizumab had observed clinical benefit across all dose-levels! glad we were the biggest recruiters in the study. #vhio #sotio 
Medical Oncologist. Clinical Investigator at @VHIO (Early Clinical Drug Development Group). Cellular Therapy and Precision Oncology enthusiastic.